Crohn’s disease is a chronic inflammatory condition that impacts the digestive tract. This clinical trial is focused on exploring new treatment options to improve the health and quality of life for those living with Crohn’s disease.
Criteria & Qualifications:
• Is at least 18 years of age or older.
• Diagnosis of Crohn’s disease (CD) for at least 3 months.
• Is willing to provide medical records.
Compensation:
Contact us for more information
| Patient Population | |
|---|---|
| Study Status | Active |
Ulcerative Colitis causes inflammation and ulcers in the colon, resulting in abdominal discomfort. This study evaluates a new treatment's efficacy and safety for those with moderate to severe conditions. It targets individuals unsatisfied with or affected by current therapies' side effects.
Criteria & Qualifications:
• Is at least 18 years of age or older.
• Diagnosed with Ulcerative Colitis.
• Is willing to provide medical records.
Compensation:
Contact Us For More information
Participate in a COVID-19 Treatment Study to Help Combat Severe Illness. Your participation can help researchers evaluate new treatment options Criteria & Qualifications: • Must be 12 years or older and diagnosed with COVID-19 within the last 5 days. • Experiencing symptoms like fever, cough, or fatigue within 5 days before randomization. • High-risk participants based on age or health conditions (e.g., chronic lung disease, cardiovascular disease, diabetes, or moderate immunosuppression). Compensation: Contact us for more information
Participate in a COVID-19 treatment study to help prevent severe illness. Join us in advancing research for high-risk individuals. Criteria & Qualifications: • Must be 18 years or older and diagnosed with COVID-19 within the last 4 days. • Experiencing at least 2 symptoms like cough, fatigue, fever, or shortness of breath in the last 4 days. • Have one or more high-risk factors such as advanced age (75+), immunosuppression, or certain chronic conditions like lung disease or obesity (BMI ≥ 35). Compensation: Contact us for more information.